{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T04:44:34Z","timestamp":1785818674569,"version":"3.56.0"},"reference-count":168,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T00:00:00Z","timestamp":1780185600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":65,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82573074"],"award-info":[{"award-number":["82573074"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82372905"],"award-info":[{"award-number":["82372905"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Guangdong Provincial Science and Technology Project Foundation","award":["2022A0505050038"],"award-info":[{"award-number":["2022A0505050038"]}]},{"name":"Young Top-notch Talent of Pearl River Talent Plan","award":["0920220228"],"award-info":[{"award-number":["0920220228"]}]},{"name":"Science and Technology Program of Guangzhou","award":["No.2025A04J3464"],"award-info":[{"award-number":["No.2025A04J3464"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04607-8","type":"journal-article","created":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T02:03:26Z","timestamp":1780193006000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Rewiring the immune circuit: programming tumor-draining lymph node immunity with nanotechnology"],"prefix":"10.1186","volume":"24","author":[{"given":"Xu","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiyan","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongwei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,31]]},"reference":[{"issue":"9","key":"4607_CR1","doi-asserted-by":"publisher","first-page":"4458","DOI":"10.3390\/ijms22094458","volume":"22","author":"LA Johnson","year":"2021","unstructured":"Johnson LA. In sickness and in health: the immunological roles of the lymphatic system. Int J Mol Sci. 2021;22(9):4458.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"4607_CR2","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/s41590-020-0635-3","volume":"21","author":"AT Krishnamurty","year":"2020","unstructured":"Krishnamurty AT, Turley SJ. Lymph node stromal cells: Cartographers of the immune system. Nat Immunol. 2020;21(4):369\u201380.","journal-title":"Nat Immunol"},{"issue":"63","key":"4607_CR3","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abg3551","volume":"6","author":"H du Bois","year":"2021","unstructured":"du Bois H, Heim TA, Lund AW. Tumor-draining lymph nodes: At the crossroads of metastasis and immunity. Sci Immunol. 2021;6(63):eabg3551.","journal-title":"Sci Immunol"},{"issue":"10","key":"4607_CR4","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1158\/1078-0432.CCR-21-0664","volume":"28","author":"K Yaddanapudi","year":"2022","unstructured":"Yaddanapudi K, Stamp BF, Subrahmanyam PB, Smolenkov A, Waigel SJ, Gosain R, et al. Single-cell immune mapping of melanoma sentinel lymph nodes reveals an actionable immunotolerant microenvironment. Clin Cancer Res. 2022;28(10):2069\u201381.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"4607_CR5","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s40425-019-0605-1","volume":"7","author":"KM van Pul","year":"2019","unstructured":"van Pul KM, Vuylsteke R, van de Ven R, Te Velde EA, Rutgers EJT, van den Tol PM, et al. Selectively hampered activation of lymph node-resident dendritic cells precedes profound T cell suppression and metastatic spread in the breast cancer sentinel lymph node. J Immunother Cancer. 2019;7(1):133.","journal-title":"J Immunother Cancer"},{"issue":"1","key":"4607_CR6","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.trecan.2023.09.006","volume":"10","author":"I Delclaux","year":"2024","unstructured":"Delclaux I, Ventre KS, Jones D, Lund AW. The tumor-draining lymph node as a reservoir for systemic immune surveillance. Trends Cancer. 2024;10(1):28\u201337.","journal-title":"Trends Cancer"},{"issue":"23","key":"4607_CR7","doi-asserted-by":"publisher","first-page":"e124507","DOI":"10.1172\/jci.insight.124507","volume":"3","author":"MF Fransen","year":"2018","unstructured":"Fransen MF, Schoonderwoerd M, Knopf P, Camps MG, Hawinkels LJ, Kneilling M, et al. Tumor-draining lymph nodes are pivotal in PD-1\/PD-L1 checkpoint therapy. JCI Insight. 2018;3(23):e124507.","journal-title":"JCI Insight"},{"issue":"7","key":"4607_CR8","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1056\/NEJMoa1310460","volume":"370","author":"DL Morton","year":"2014","unstructured":"Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Nieweg OE, Roses DF, et al. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med. 2014;370(7):599\u2013609.","journal-title":"N Engl J Med"},{"issue":"2","key":"4607_CR9","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ccell.2016.06.003","volume":"30","author":"EW Roberts","year":"2016","unstructured":"Roberts EW, Broz ML, Binnewies M, Headley MB, Nelson AE, Wolf DM, et al. Critical Role for CD103(+)\/CD141(+) Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma. Cancer Cell. 2016;30(2):324\u201336.","journal-title":"Cancer Cell"},{"issue":"9","key":"4607_CR10","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1158\/1078-0432.CCR-05-2431","volume":"12","author":"RJ Vuylsteke","year":"2006","unstructured":"Vuylsteke RJ, Molenkamp BG, van Leeuwen PA, Meijer S, Wijnands PG, Haanen JB, et al. Tumor-specific CD8\u2009+\u2009T cell reactivity in the sentinel lymph node of GM-CSF-treated stage I melanoma patients is associated with high myeloid dendritic cell content. Clin Cancer Res. 2006;12(9):2826\u201333.","journal-title":"Clin Cancer Res"},{"issue":"10","key":"4607_CR11","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1007\/s00262-019-02330-y","volume":"68","author":"J Rotman","year":"2019","unstructured":"Rotman J, Koster BD, Jordanova ES, Heeren AM, de Gruijl TD. Unlocking the therapeutic potential of primary tumor-draining lymph nodes. Cancer Immunol Immunother. 2019;68(10):1681\u20138.","journal-title":"Cancer Immunol Immunother"},{"key":"4607_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.643291","volume":"12","author":"KM van Pul","year":"2021","unstructured":"van Pul KM, Fransen MF, van de Ven R, de Gruijl TD. Immunotherapy goes local: the central role of lymph nodes in driving tumor infiltration and efficacy. Front Immunol. 2021;12:643291.","journal-title":"Front Immunol"},{"issue":"1","key":"4607_CR13","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2020.1830513","volume":"9","author":"YL Li","year":"2020","unstructured":"Li YL, Chen CH, Chen JY, Lai YS, Wang SC, Jiang SS, et al. Single-cell analysis reveals immune modulation and metabolic switch in tumor-draining lymph nodes. Oncoimmunology. 2020;9(1):1830513.","journal-title":"Oncoimmunology"},{"key":"4607_CR14","first-page":"0346","volume":"7","author":"X Mao","year":"2024","unstructured":"Mao X, Tang X, Pan H, Yu M, Ji S, Qiu W, et al. B Cells and IL-21-Producing Follicular Helper T Cells Cooperate to Determine the Dynamic Alterations of Premetastatic Tumor Draining Lymph Nodes of Breast Cancer. Res (Wash D C). 2024;7:0346.","journal-title":"Res (Wash D C)"},{"issue":"7","key":"4607_CR15","doi-asserted-by":"publisher","first-page":"111171","DOI":"10.1016\/j.celrep.2022.111171","volume":"40","author":"E Pylaeva","year":"2022","unstructured":"Pylaeva E, Korschunow G, Spyra I, Bordbari S, Siakaeva E, Ozel I, et al. During early stages of cancer, neutrophils initiate anti-tumor immune responses in tumor-draining lymph nodes. Cell Rep. 2022;40(7):111171.","journal-title":"Cell Rep"},{"issue":"9","key":"4607_CR16","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1158\/2159-8290.CD-24-1847","volume":"15","author":"BM Kahn","year":"2025","unstructured":"Kahn BM, Ng RWS, Kim IK, Eskandarian C, Chen CO, Huang B, et al. Intrinsic Properties of the Lymph Node Render It Immunologically Susceptible to Metastasis. Cancer Discov. 2025;15(9):1949\u201368.","journal-title":"Cancer Discov"},{"issue":"5","key":"4607_CR17","doi-asserted-by":"publisher","first-page":"955\u2009\u2212\u200969.e10","DOI":"10.1016\/j.ccell.2025.02.017","volume":"43","author":"S Lamorte","year":"2025","unstructured":"Lamorte S, Quevedo R, Jin R, Neufeld L, Liu ZQ, Ciudad MT, et al. Lymph node macrophages drive immune tolerance and resistance to cancer therapy by induction of the immune-regulatory cytokine IL-33. Cancer Cell. 2025;43(5):955\u2009\u2212\u200969.e10.","journal-title":"Cancer Cell"},{"issue":"9","key":"4607_CR18","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1172\/JCI31911","volume":"117","author":"MD Sharma","year":"2007","unstructured":"Sharma MD, Baban B, Chandler P, Hou DY, Singh N, Yagita H, et al. Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase. J Clin Invest. 2007;117(9):2570\u201382.","journal-title":"J Clin Invest"},{"key":"4607_CR19","doi-asserted-by":"publisher","first-page":"101469","DOI":"10.1016\/j.tranon.2022.101469","volume":"23","author":"K Piersiala","year":"2022","unstructured":"Piersiala K, da Silva PFN, Lagebro V, Kolev A, Starkhammar M, Elliot A, et al. Tumour-draining lymph nodes in head and neck cancer are characterized by accumulation of CTLA-4 and PD-1 expressing Treg cells. Transl Oncol. 2022;23:101469.","journal-title":"Transl Oncol"},{"issue":"9","key":"4607_CR20","doi-asserted-by":"publisher","first-page":"3971","DOI":"10.21873\/anticanres.17755","volume":"45","author":"M Aoki","year":"2025","unstructured":"Aoki M, Kamimura GO, Tsuneyoshi Y, Morizono S, Tokunaga T, Harada-Takeda A, et al. Thorough Lymphadenectomy Impairs Immunotherapy Outcomes for Postoperative Intrathoracic Recurrence of Non-small Cell Lung Cancer. Anticancer Res. 2025;45(9):3971\u201381.","journal-title":"Anticancer Res"},{"issue":"2","key":"4607_CR21","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.21873\/anticanres.18010","volume":"46","author":"YI Iwasa","year":"2026","unstructured":"Iwasa YI, Hori K, Yokota Y, Kitoh R, Yamazaki S, Okubo T, et al. Neck Dissection and Immune Checkpoint Inhibitor Efficacy in Head and Neck Cancer: A Retrospective Study. Anticancer Res. 2026;46(2):1079\u201387.","journal-title":"Anticancer Res"},{"issue":"1","key":"4607_CR22","doi-asserted-by":"publisher","first-page":"7015","DOI":"10.1038\/s41467-022-34676-w","volume":"13","author":"LB Darragh","year":"2022","unstructured":"Darragh LB, Gadwa J, Pham TT, Van Court B, Neupert B, Olimpo NA, et al. Elective nodal irradiation mitigates local and systemic immunity generated by combination radiation and immunotherapy in head and neck tumors. Nat Commun. 2022;13(1):7015.","journal-title":"Nat Commun"},{"key":"4607_CR23","doi-asserted-by":"publisher","first-page":"13579","DOI":"10.2147\/IJN.S488480","volume":"19","author":"YN Xu","year":"2024","unstructured":"Xu YN, Bai X, Chen JL, Wu X, Yin D, Yuan G, et al. Tracing Sentinel Lymph Nodes and Inhibiting Lymphatic Metastasis with TiN Nanobipyramids Through Photothermal Therapy. Int J Nanomed. 2024;19:13579\u201392.","journal-title":"Int J Nanomed"},{"issue":"37","key":"4607_CR24","doi-asserted-by":"publisher","first-page":"4856","DOI":"10.1002\/smll.201501197","volume":"11","author":"C Liang","year":"2015","unstructured":"Liang C, Song X, Chen Q, Liu T, Song G, Peng R, et al. Magnetic Field-Enhanced Photothermal Ablation of Tumor Sentinel Lymph Nodes to Inhibit Cancer Metastasis. Small. 2015;11(37):4856\u201363.","journal-title":"Small"},{"issue":"1","key":"4607_CR25","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s12951-023-02026-7","volume":"21","author":"Y Dai","year":"2023","unstructured":"Dai Y, Yu X, Leng Y, Peng X, Wang J, Zhao Y, et al. Effective treatment of metastatic sentinel lymph nodes by dual-targeting melittin nanoparticles. J Nanobiotechnol. 2023;21(1):245.","journal-title":"J Nanobiotechnol"},{"issue":"5","key":"4607_CR26","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1158\/2326-6066.CIR-14-0019-T","volume":"2","author":"L Jeanbart","year":"2014","unstructured":"Jeanbart L, Ballester M, de Titta A, Corth\u00e9sy P, Romero P, Hubbell JA, et al. Enhancing efficacy of anticancer vaccines by targeted delivery to tumor-draining lymph nodes. Cancer Immunol Res. 2014;2(5):436\u201347.","journal-title":"Cancer Immunol Res"},{"issue":"2","key":"4607_CR27","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.biomaterials.2013.10.003","volume":"35","author":"SN Thomas","year":"2014","unstructured":"Thomas SN, Vokali E, Lund AW, Hubbell JA, Swartz MA. Targeting the tumor-draining lymph node with adjuvanted nanoparticles reshapes the anti-tumor immune response. Biomaterials. 2014;35(2):814\u201324.","journal-title":"Biomaterials"},{"issue":"1","key":"4607_CR28","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1186\/s12951-025-03537-1","volume":"23","author":"W Cao","year":"2025","unstructured":"Cao W, Yang K, Jin G, Chen Q, Shao Z, Lu X, et al. Nanoliposomal PD-1 antagonist target tumor-draining lymph nodes to revitalize T cells and improve anti-tumor effect in hepatocellular carcinoma. J Nanobiotechnol. 2025;23(1):549.","journal-title":"J Nanobiotechnol"},{"key":"4607_CR29","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1146\/annurev-bioeng-092222-034906","volume":"25","author":"K Maisel","year":"2023","unstructured":"Maisel K, McClain CA, Bogseth A, Thomas SN. Nanotechnologies for physiology-informed drug delivery to the lymphatic system. Annu Rev Biomed Eng. 2023;25:233\u201356.","journal-title":"Annu Rev Biomed Eng"},{"issue":"12","key":"4607_CR30","doi-asserted-by":"publisher","first-page":"5139","DOI":"10.1007\/s00018-021-03842-6","volume":"78","author":"X Peng","year":"2021","unstructured":"Peng X, Wang J, Zhou F, Liu Q, Zhang Z. Nanoparticle-based approaches to target the lymphatic system for antitumor treatment. Cell Mol Life Sci. 2021;78(12):5139\u201361.","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"4607_CR31","doi-asserted-by":"publisher","first-page":"565","DOI":"10.3390\/pharmaceutics15020565","volume":"15","author":"J Lee","year":"2023","unstructured":"Lee J, Kang S, Park H, Sun JG, Kim EC, Shim G. Nanoparticles for lymph node-directed delivery. Pharmaceutics. 2023;15(2):565.","journal-title":"Pharmaceutics"},{"issue":"29","key":"4607_CR32","doi-asserted-by":"publisher","first-page":"8098","DOI":"10.1073\/pnas.1600816113","volume":"113","author":"L Nuhn","year":"2016","unstructured":"Nuhn L, Vanparijs N, De Beuckelaer A, Lybaert L, Verstraete G, Deswarte K, et al. pH-degradable imidazoquinoline-ligated nanogels for lymph node-focused immune activation. Proc Natl Acad Sci U S A. 2016;113(29):8098\u2013103.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"26","key":"4607_CR33","doi-asserted-by":"publisher","first-page":"9872","DOI":"10.1021\/jacs.1c03772","volume":"143","author":"A Huppertsberg","year":"2021","unstructured":"Huppertsberg A, Kaps L, Zhong Z, Schmitt S, Stickdorn J, Deswarte K, et al. Squaric Ester-Based, pH-Degradable Nanogels: Modular Nanocarriers for Safe, Systemic Administration of Toll-like Receptor 7\/8 Agonistic Immune Modulators. J Am Chem Soc. 2021;143(26):9872\u201383.","journal-title":"J Am Chem Soc"},{"key":"4607_CR34","volume":"11","author":"J Yao","year":"2026","unstructured":"Yao J, Liu L, Teng X, Chu D, Ding S, Li H, et al. Bioinspired and stimuli-responsive nanocomposites for targeted therapy in ovarian and endometrial tumors. Int J Pharm X. 2026;11:100493.","journal-title":"Int J Pharm X"},{"issue":"16","key":"4607_CR35","doi-asserted-by":"publisher","first-page":"9171","DOI":"10.1021\/acsomega.9b04390","volume":"5","author":"LA Manzanares-Guevara","year":"2020","unstructured":"Manzanares-Guevara LA, Licea-Claverie A, Oroz-Parra I, Bernaldez-Sarabia J, Diaz-Castillo F, Licea-Navarro AF. Smart nanoformulation based on stimuli-responsive nanogels and Curcumin: promising therapy against colon cancer. ACS Omega. 2020;5(16):9171\u201384.","journal-title":"ACS Omega"},{"issue":"9","key":"4607_CR36","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.3390\/polym12092150","volume":"12","author":"MA Gonz\u00e1lez-Ay\u00f3n","year":"2020","unstructured":"Gonz\u00e1lez-Ay\u00f3n MA, Licea-Claverie A, Sa\u00f1udo-Barajas JA. Different strategies for the preparation of Galactose-functionalized thermo-responsive nanogels with potential as smart drug delivery systems. Polymers. 2020;12(9):2150.","journal-title":"Polymers"},{"issue":"7","key":"4607_CR37","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.3390\/pharmaceutics14071372","volume":"14","author":"Z Cheng","year":"2022","unstructured":"Cheng Z, Que H, Chen L, Sun Q, Wei X. Nanomaterial-based drug delivery system targeting lymph nodes. Pharmaceutics. 2022;14(7):1372 .","journal-title":"Pharmaceutics"},{"issue":"14","key":"4607_CR38","doi-asserted-by":"publisher","first-page":"e2005241","DOI":"10.1002\/smll.202005241","volume":"17","author":"TJ Carter","year":"2021","unstructured":"Carter TJ, Agliardi G, Lin FY, Ellis M, Jones C, Robson M, et al. Potential of Magnetic Hyperthermia to Stimulate Localized Immune Activation. Small. 2021;17(14):e2005241.","journal-title":"Small"},{"issue":"19","key":"4607_CR39","doi-asserted-by":"publisher","first-page":"4245","DOI":"10.1039\/C9TB02238D","volume":"8","author":"X Wang","year":"2020","unstructured":"Wang X, Li B, Jing H, Dong X, Leng X. MWCNT-mediated combinatorial photothermal ablation and chemo-immunotherapy strategy for the treatment of melanoma. J Mater Chem B. 2020;8(19):4245\u201358.","journal-title":"J Mater Chem B"},{"key":"4607_CR40","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.biomaterials.2018.10.031","volume":"190\u2013191","author":"I Mottas","year":"2019","unstructured":"Mottas I, Bekdemir A, Cereghetti A, Spagnuolo L, Yang YS, M\u00fcller M, et al. Amphiphilic nanoparticle delivery enhances the anticancer efficacy of a TLR7 ligand via local immune activation. Biomaterials. 2019;190\u2013191:111\u201320.","journal-title":"Biomaterials"},{"issue":"15","key":"4607_CR41","doi-asserted-by":"publisher","first-page":"4581","DOI":"10.1182\/bloodadvances.2022008040","volume":"6","author":"AY Lin","year":"2022","unstructured":"Lin AY, Choi B, Sim T, Yang E, Choi H, Behdad A, et al. Enhanced systemic antilymphoma immune response by photothermal therapy with CpG deoxynucleotide-coated nanoparticles. Blood Adv. 2022;6(15):4581\u201392.","journal-title":"Blood Adv"},{"issue":"7","key":"4607_CR42","doi-asserted-by":"publisher","first-page":"5297","DOI":"10.1021\/am500661j","volume":"6","author":"J Jeong","year":"2014","unstructured":"Jeong J, Kwon EK, Cheong TC, Park H, Cho NH, Kim W. Synthesis of multifunctional Fe\u2083O\u2084-CdSe\/ZnS nanoclusters coated with Lipid A toward dendritic cell-based immunotherapy. ACS Appl Mater Interfaces. 2014;6(7):5297\u2013307.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"9","key":"4607_CR43","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1038\/jid.2009.39","volume":"129","author":"M Sato","year":"2009","unstructured":"Sato M, Yamashita T, Ohkura M, Osai Y, Sato A, Takada T, et al. N-propionyl-cysteaminylphenol-magnetite conjugate (NPrCAP\/M) is a nanoparticle for the targeted growth suppression of melanoma cells. J Invest Dermatology. 2009;129(9):2233\u201341.","journal-title":"J Invest Dermatology"},{"issue":"1","key":"4607_CR44","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12951-019-0520-0","volume":"17","author":"L Sanz-Ortega","year":"2019","unstructured":"Sanz-Ortega L, Portilla Y, P\u00e9rez-Yag\u00fce S, Barber DF. Magnetic targeting of adoptively transferred tumour-specific nanoparticle-loaded CD8(+) T cells does not improve their tumour infiltration in a mouse model of cancer but promotes the retention of these cells in tumour-draining lymph nodes. J Nanobiotechnol. 2019;17(1):87.","journal-title":"J Nanobiotechnol"},{"issue":"29","key":"4607_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202200522","volume":"18","author":"X Wu","year":"2022","unstructured":"Wu X, Wang L, Xu YN, Chen JL, Luo KQ, Yuan MH, et al. Chemo-phototherapy with Carfilzomib-encapsulated TiN nanoshells suppressing tumor growth and lymphatic metastasis. Small. 2022;18(29):e2200522.","journal-title":"Small"},{"issue":"12","key":"4607_CR46","doi-asserted-by":"publisher","first-page":"4166","DOI":"10.7150\/thno.85843","volume":"13","author":"Z Lin","year":"2023","unstructured":"Lin Z, Jiang C, Wang P, Chen Q, Wang B, Fu X, et al. Caveolin-mediated cytosolic delivery of spike nanoparticle enhances antitumor immunity of neoantigen vaccine for hepatocellular carcinoma. Theranostics. 2023;13(12):4166\u201381.","journal-title":"Theranostics"},{"issue":"11","key":"4607_CR47","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3390\/pharmaceutics13111811","volume":"13","author":"K Yang","year":"2021","unstructured":"Yang K, Choi C, Cho H, Ahn WG, Kim SY, Shin SW, et al. Antigen-capturing mesoporous silica nanoparticles enhance the radiation-induced abscopal effect in murine hepatocellular carcinoma Hepa1-6 models. Pharmaceutics. 2021;13(11):181.","journal-title":"Pharmaceutics"},{"issue":"11","key":"4607_CR48","doi-asserted-by":"publisher","first-page":"3026","DOI":"10.1039\/D0BM00395F","volume":"8","author":"Y Hu","year":"2020","unstructured":"Hu Y, Tang Y, Zhang XJ, Yang XT, Tang YY, Li S, et al. Dendritic cells reprogrammed by CEA messenger RNA loaded multi-functional silica nanospheres for imaging-guided cancer immunotherapy. Biomater Sci. 2020;8(11):3026\u201331.","journal-title":"Biomater Sci"},{"issue":"1","key":"4607_CR49","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12957-016-0925-2","volume":"14","author":"J Du","year":"2016","unstructured":"Du J, Zhang Y, Ming J, Liu J, Zhong L, Liang Q, et al. Evaluation of the tracing effect of carbon nanoparticle and carbon nanoparticle-epirubicin suspension in axillary lymph node dissection for breast cancer treatment. World J Surg Oncol. 2016;14(1):164.","journal-title":"World J Surg Oncol"},{"key":"4607_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.msec.2021.112586","volume":"134","author":"MRM Radzi","year":"2022","unstructured":"Radzi MRM, Johari NA, Zawawi W, Zawawi NA, Latiff NA, Malek N, et al. In vivo evaluation of oxidized multiwalled-carbon nanotubes-mediated hyperthermia treatment for breast cancer. Biomater Adv. 2022;134:112586.","journal-title":"Biomater Adv"},{"issue":"9","key":"4607_CR51","doi-asserted-by":"publisher","first-page":"5505","DOI":"10.1021\/acs.chemrev.3c00705","volume":"124","author":"MA Beach","year":"2024","unstructured":"Beach MA, Nayanathara U, Gao Y, Zhang C, Xiong Y, Wang Y, et al. Polymeric Nanoparticles for Drug Delivery. Chem Rev. 2024;124(9):5505\u2013616.","journal-title":"Chem Rev"},{"issue":"2","key":"4607_CR52","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jconrel.2012.01.043","volume":"161","author":"F Danhier","year":"2012","unstructured":"Danhier F, Ansorena E, Silva JM, Coco R, Le Breton A, Pr\u00e9at V. PLGA-based nanoparticles: an overview of biomedical applications. J Control Release. 2012;161(2):505\u201322.","journal-title":"J Control Release"},{"key":"4607_CR53","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.biomaterials.2018.02.034","volume":"164","author":"H Kim","year":"2018","unstructured":"Kim H, Niu L, Larson P, Kucaba TA, Murphy KA, James BR, et al. Polymeric nanoparticles encapsulating novel TLR7\/8 agonists as immunostimulatory adjuvants for enhanced cancer immunotherapy. Biomaterials. 2018;164:38\u201353.","journal-title":"Biomaterials"},{"issue":"8","key":"4607_CR54","doi-asserted-by":"publisher","first-page":"7850","DOI":"10.1021\/acsami.8b22309","volume":"11","author":"J Jin","year":"2019","unstructured":"Jin J, Krishnamachary B, Barnett JD, Chatterjee S, Chang D, Mironchik Y, et al. Human Cancer Cell Membrane-Coated Biomimetic Nanoparticles Reduce Fibroblast-Mediated Invasion and Metastasis and Induce T-Cells. ACS Appl Mater Interfaces. 2019;11(8):7850\u201361.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"7","key":"4607_CR55","doi-asserted-by":"publisher","first-page":"6918","DOI":"10.1021\/acsnano.5b01042","volume":"9","author":"Y Guo","year":"2015","unstructured":"Guo Y, Wang D, Song Q, Wu T, Zhuang X, Bao Y, et al. Erythrocyte Membrane-Enveloped Polymeric Nanoparticles as Nanovaccine for Induction of Antitumor Immunity against Melanoma. ACS Nano. 2015;9(7):6918\u201333.","journal-title":"ACS Nano"},{"key":"4607_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2020.119795","volume":"235","author":"S Zhou","year":"2020","unstructured":"Zhou S, Huang Y, Chen Y, Liu S, Xu M, Jiang T, et al. Engineering ApoE3-incorporated biomimetic nanoparticle for efficient vaccine delivery to dendritic cells via macropinocytosis to enhance cancer immunotherapy. Biomaterials. 2020;235:119795.","journal-title":"Biomaterials"},{"key":"4607_CR57","first-page":"5981","volume":"10","author":"MB Heo","year":"2015","unstructured":"Heo MB, Kim SY, Yun WS, Lim YT. Sequential delivery of an anticancer drug and combined immunomodulatory nanoparticles for efficient chemoimmunotherapy. Int J Nanomedicine. 2015;10:5981\u201392.","journal-title":"Int J Nanomedicine"},{"key":"4607_CR58","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.biomaterials.2014.10.050","volume":"38","author":"Z Luo","year":"2015","unstructured":"Luo Z, Wang C, Yi H, Li P, Pan H, Liu L, et al. Nanovaccine loaded with poly I:C and STAT3 siRNA robustly elicits anti-tumor immune responses through modulating tumor-associated dendritic cells in vivo. Biomaterials. 2015;38:50\u201360.","journal-title":"Biomaterials"},{"issue":"7","key":"4607_CR59","doi-asserted-by":"publisher","first-page":"5707","DOI":"10.1021\/acsabm.1c00480","volume":"4","author":"Z He","year":"2021","unstructured":"He Z, Jia H, Zheng M, Wang H, Yang W, Gao L, et al. Trp2 Peptide-Assembled Nanoparticles with Intrinsically Self-Chelating (64)Cu Properties for PET Imaging Tracking and Dendritic Cell-Based Immunotherapy against Melanoma. ACS Appl Bio Mater. 2021;4(7):5707\u201316.","journal-title":"ACS Appl Bio Mater"},{"issue":"Pt 3","key":"4607_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.135327","volume":"279","author":"S Victoria","year":"2024","unstructured":"Victoria S, Castro A, Pittini A, Olivera D, Russo S, Cebrian I, et al. Formulating a TMEM176B blocker in chitosan nanoparticles uncouples its paradoxical roles in innate and adaptive antitumoral immunity. Int J Biol Macromol. 2024;279(Pt 3):135327.","journal-title":"Int J Biol Macromol"},{"issue":"9","key":"4607_CR61","doi-asserted-by":"publisher","first-page":"3704","DOI":"10.1021\/acs.biomac.0c00812","volume":"21","author":"AAA Smith","year":"2020","unstructured":"Smith AAA, Gale EC, Roth GA, Maikawa CL, Correa S, Yu AC, et al. Nanoparticles Presenting Potent TLR7\/8 Agonists Enhance Anti-PD-L1 Immunotherapy in Cancer Treatment. Biomacromolecules. 2020;21(9):3704\u201312.","journal-title":"Biomacromolecules"},{"key":"4607_CR62","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.canlet.2020.08.009","volume":"493","author":"H Tao","year":"2020","unstructured":"Tao H, Cheng L, Liu L, Wang H, Jiang Z, Qiang X, et al. A PD-1 peptide antagonist exhibits potent anti-tumor and immune regulatory activity. Cancer Lett. 2020;493:91\u2013101.","journal-title":"Cancer Lett"},{"key":"4607_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2025.102835","volume":"68","author":"S Kulkarni","year":"2025","unstructured":"Kulkarni S, Kumar A, Soman S, Pandey A, Subramanian S, Mutalik S. Surface-modified (99m)Tc-lactoferrin nanoparticles as tracers for sentinel lymph node mapping. Nanomedicine. 2025;68:102835.","journal-title":"Nanomedicine"},{"key":"4607_CR64","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.biomaterials.2018.08.016","volume":"182","author":"LJ Ochyl","year":"2018","unstructured":"Ochyl LJ, Bazzill JD, Park C, Xu Y, Kuai R, Moon JJ. PEGylated tumor cell membrane vesicles as a new vaccine platform for cancer immunotherapy. Biomaterials. 2018;182:157\u201366.","journal-title":"Biomaterials"},{"key":"4607_CR65","doi-asserted-by":"publisher","first-page":"114714","DOI":"10.1016\/j.colsurfb.2025.114714","volume":"253","author":"H Duan","year":"2025","unstructured":"Duan H, Li H, Su Q, Liu P, Zhang M, Chen X, et al. Galectin-1-targeted theranostic nanoprobe for multimodal imaging and photothermal therapy in cervical cancer lymph node metastases. Colloids Surf B. 2025;253:114714.","journal-title":"Colloids Surf B"},{"issue":"35","key":"4607_CR66","doi-asserted-by":"publisher","first-page":"e2400194121","DOI":"10.1073\/pnas.2400194121","volume":"121","author":"Y Hu","year":"2024","unstructured":"Hu Y, Tzeng SY, Cheng L, Lin J, Villabona-Rueda A, Yu S, et al. Supramolecular assembly of polycation\/mRNA nanoparticles and in vivo monocyte programming. Proc Natl Acad Sci USA. 2024;121(35):e2400194121.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4607_CR67","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jconrel.2022.03.006","volume":"345","author":"H Liu","year":"2022","unstructured":"Liu H, Hu Z, Chen H, Yan Y, Le Z, Wei C, et al. Self-degradable poly(\u03b2-amino ester)s promote endosomal escape of antigen and agonist. J Control Release. 2022;345:91\u2013100.","journal-title":"J Control Release"},{"issue":"23","key":"4607_CR68","doi-asserted-by":"publisher","DOI":"10.1002\/marc.202300438","volume":"44","author":"M Zhang","year":"2023","unstructured":"Zhang M, Chen W, Ju Y, Zhao H, Wang C. Polymer-protein nanovaccine synthesized via reactive self-assembly with potential application in cancer immunotherapy: physicochemical and biological characterization in vitro and in vivo. Macromol Rapid Commun. 2023;44(23):e2300438.","journal-title":"Macromol Rapid Commun"},{"issue":"Pt 4","key":"4607_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.141740","volume":"306","author":"R Swami","year":"2025","unstructured":"Swami R, Popli P, Sal K, Challa RR, Vallamkonda B, Garg M, et al. A review on biomacromolecular ligand-directed nanoparticles: new era in macrophage targeting. Int J Biol Macromol. 2025;306(Pt 4):141740.","journal-title":"Int J Biol Macromol"},{"issue":"9","key":"4607_CR70","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.it.2024.07.007","volume":"45","author":"GI Kane","year":"2024","unstructured":"Kane GI, Brassil ML, Diaz-Infante MB, Atukorale PU. Nanocarrier design for pathogen-inspired innate immune agonist delivery. Trends Immunol. 2024;45(9):678\u201392.","journal-title":"Trends Immunol"},{"issue":"39","key":"4607_CR71","doi-asserted-by":"publisher","first-page":"26770","DOI":"10.1021\/acsnano.4c07360","volume":"18","author":"V Lensch","year":"2024","unstructured":"Lensch V, Gabba A, Hincapie R, Bhagchandani SH, Basak A, Alam MM, et al. Carbohydrate-lectin interactions reprogram dendritic cells to promote type 1 anti-tumor immunity. ACS Nano. 2024;18(39):26770\u201383.","journal-title":"ACS Nano"},{"key":"4607_CR72","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.biomaterials.2016.10.047","volume":"113","author":"GN Shi","year":"2017","unstructured":"Shi GN, Zhang CN, Xu R, Niu JF, Song HJ, Zhang XY, et al. Enhanced antitumor immunity by targeting dendritic cells with tumor cell lysate-loaded chitosan nanoparticles vaccine. Biomaterials. 2017;113:191\u2013202.","journal-title":"Biomaterials"},{"key":"4607_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121489","volume":"284","author":"Y Xu","year":"2022","unstructured":"Xu Y, Ma S, Zhao J, Chen H, Si X, Huang Z, et al. Mannan-decorated pathogen-like polymeric nanoparticles as nanovaccine carriers for eliciting superior anticancer immunity. Biomaterials. 2022;284:121489.","journal-title":"Biomaterials"},{"issue":"3","key":"4607_CR74","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1021\/acs.nanolett.9b03483","volume":"20","author":"S Son","year":"2020","unstructured":"Son S, Nam J, Zenkov I, Ochyl LJ, Xu Y, Scheetz L, et al. Sugar-Nanocapsules Imprinted with Microbial Molecular Patterns for mRNA Vaccination. Nano Lett. 2020;20(3):1499\u2013509.","journal-title":"Nano Lett"},{"issue":"1","key":"4607_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27750-2","volume":"13","author":"J Xu","year":"2022","unstructured":"Xu J, Ma Q, Zhang Y, Fei Z, Sun Y, Fan Q, et al. Yeast-derived nanoparticles remodel the immunosuppressive microenvironment in tumor and tumor-draining lymph nodes to suppress tumor growth. Nat Commun. 2022;13(1):110.","journal-title":"Nat Commun"},{"issue":"10","key":"4607_CR76","first-page":"3358","volume":"6","author":"Y Zeng","year":"2021","unstructured":"Zeng Y, Xiang Y, Sheng R, Tom\u00e1s H, Rodrigues J, Gu Z, et al. Polysaccharide-based nanomedicines for cancer immunotherapy: A review. Bioact Mater. 2021;6(10):3358\u201382.","journal-title":"Bioact Mater"},{"issue":"45","key":"4607_CR77","doi-asserted-by":"publisher","first-page":"42661","DOI":"10.1021\/acsami.9b16814","volume":"11","author":"G Pang","year":"2019","unstructured":"Pang G, Chen C, Liu Y, Jiang T, Yu H, Wu Y, et al. Bioactive Polysaccharide Nanoparticles Improve Radiation-Induced Abscopal Effect through Manipulation of Dendritic Cells. ACS Appl Mater Interfaces. 2019;11(45):42661\u201370.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"9","key":"4607_CR78","doi-asserted-by":"publisher","first-page":"9209","DOI":"10.1021\/nn502975r","volume":"8","author":"D Muraoka","year":"2014","unstructured":"Muraoka D, Harada N, Hayashi T, Tahara Y, Momose F, Sawada S, et al. Nanogel-based immunologically stealth vaccine targets macrophages in the medulla of lymph node and induces potent antitumor immunity. ACS Nano. 2014;8(9):9209\u201318.","journal-title":"ACS Nano"},{"key":"4607_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2020.116270","volume":"240","author":"X Yang","year":"2020","unstructured":"Yang X, Yu T, Zeng Y, Lian K, Zhou X, Li S, et al. Tumor-draining lymph node targeting chitosan micelles as antigen-capturing adjuvants for personalized immunotherapy. Carbohydr Polym. 2020;240:116270.","journal-title":"Carbohydr Polym"},{"issue":"1","key":"4607_CR80","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.nano.2013.06.007","volume":"10","author":"N Li","year":"2014","unstructured":"Li N, Peng LH, Chen X, Zhang TY, Shao GF, Liang WQ, et al. Antigen-loaded nanocarriers enhance the migration of stimulated Langerhans cells to draining lymph nodes and induce effective transcutaneous immunization. Nanomedicine: Nanatechnol Biology Med. 2014;10(1):215\u201323.","journal-title":"Nanomedicine: Nanatechnol Biology Med"},{"issue":"1","key":"4607_CR81","doi-asserted-by":"publisher","DOI":"10.1007\/s40820-023-01125-2","volume":"15","author":"Y Xia","year":"2023","unstructured":"Xia Y, Fu S, Ma Q, Liu Y, Zhang N. Application of nano-delivery systems in lymph nodes for tumor immunotherapy. Nano-Micro Lett. 2023;15(1):145.","journal-title":"Nano-Micro Lett"},{"issue":"7","key":"4607_CR82","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1016\/j.celrep.2019.10.008","volume":"29","author":"C Havenar-Daughton","year":"2019","unstructured":"Havenar-Daughton C, Carnathan DG, Boopathy AV, Upadhyay AA, Murrell B, Reiss SM, et al. Rapid Germinal Center and Antibody Responses in Non-human Primates after a Single Nanoparticle Vaccine Immunization. Cell Rep. 2019;29(7):1756\u2013e668.","journal-title":"Cell Rep"},{"issue":"4","key":"4607_CR83","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202404316","volume":"14","author":"Y Kim","year":"2025","unstructured":"Kim Y, Lee S, Yoon J, Shin Y, Kang S, Kim SY, et al. Neoantigen-displaying protein nanoparticles as a therapeutic cancer vaccine against melanoma. Adv Healthc Mater. 2025;14(4):e2404316.","journal-title":"Adv Healthc Mater"},{"key":"4607_CR84","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.nano.2018.11.009","volume":"16","author":"W Wang","year":"2019","unstructured":"Wang W, Liu Z, Zhou X, Guo Z, Zhang J, Zhu P, et al. Ferritin nanoparticle-based SpyTag\/SpyCatcher-enabled click vaccine for tumor immunotherapy. Nanomedicine. 2019;16:69\u201378.","journal-title":"Nanomedicine"},{"key":"4607_CR85","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.biomaterials.2016.01.056","volume":"86","author":"NM Molino","year":"2016","unstructured":"Molino NM, Neek M, Tucker JA, Nelson EL, Wang SW. Viral-mimicking protein nanoparticle vaccine for eliciting anti-tumor responses. Biomaterials. 2016;86:83\u201391.","journal-title":"Biomaterials"},{"issue":"24","key":"4607_CR86","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202307754","volume":"11","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Jiang L, Huang S, Lian C, Liang H, Xing Y, et al. Sulfonium-stapled peptides-based neoantigen delivery system for personalized tumor immunotherapy and prevention. Adv Sci. 2024;11(24):e2307754.","journal-title":"Adv Sci"},{"key":"4607_CR87","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.biomaterials.2016.05.008","volume":"98","author":"Y Qian","year":"2016","unstructured":"Qian Y, Jin H, Qiao S, Dai Y, Huang C, Lu L, et al. Targeting dendritic cells in lymph node with an antigen peptide-based nanovaccine for cancer immunotherapy. Biomaterials. 2016;98:171\u201383.","journal-title":"Biomaterials"},{"issue":"12","key":"4607_CR88","doi-asserted-by":"publisher","first-page":"e2102781","DOI":"10.1002\/adhm.202102781","volume":"11","author":"Y Liu","year":"2022","unstructured":"Liu Y, Li H, Zhao H, Hao Y, Van Herck S, Xu Z, et al. In Situ Tumor Vaccination with Calcium-Linked Degradable Coacervate Nanocomplex Co-Delivering Photosensitizer and TLR7\/8 Agonist to Trigger Effective Anti-Tumor Immune Responses. Adv Healthc Mater. 2022;11(12):e2102781.","journal-title":"Adv Healthc Mater"},{"key":"4607_CR89","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.actbio.2022.12.039","volume":"158","author":"L Su","year":"2023","unstructured":"Su L, Pan W, Li X, Zhou X, Ma X, Min Y. Utilizing chemotherapy-induced tumor RNA nanoparticles to improve cancer chemoimmunotherapy. Acta Biomater. 2023;158:698\u2013707.","journal-title":"Acta Biomater"},{"issue":"5","key":"4607_CR90","doi-asserted-by":"publisher","first-page":"4056","DOI":"10.1021\/acsnano.3c07284","volume":"18","author":"T Yip","year":"2024","unstructured":"Yip T, Qi X, Yan H, Chang Y. RNA origami functions as a self-adjuvanted nanovaccine platform for cancer immunotherapy. ACS Nano. 2024;18(5):4056\u201367.","journal-title":"ACS Nano"},{"issue":"3","key":"4607_CR91","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.3390\/ijms23031350","volume":"23","author":"M Nagaoka","year":"2022","unstructured":"Nagaoka M, Liao W, Kusamori K, Nishikawa M. Targeted delivery of immunostimulatory CpG oligodeoxynucleotides to antigen-presenting cells in draining lymph nodes by Stearic Acid modification and nanostructurization. Int J Mol Sci. 2022;23(3):1350.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"4607_CR92","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.apsb.2026.01.019","volume":"16","author":"X Zhang","year":"2026","unstructured":"Zhang X, Jing H, Wang Y, Mu S, Wang X, Zheng H, et al. Membrane-derived biomimetic nanovesicles in anti-tumor immunotherapy: advances and outlook. Acta Pharm Sin B. 2026;16(3):1388\u2013420.","journal-title":"Acta Pharm Sin B"},{"key":"4607_CR93","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.923598","volume":"13","author":"C Xu","year":"2022","unstructured":"Xu C, Ju D, Zhang X. Cell membrane-derived vesicle: A novel vehicle for cancer immunotherapy. Front Immunol. 2022;13:923598.","journal-title":"Front Immunol"},{"issue":"28","key":"4607_CR94","doi-asserted-by":"publisher","first-page":"e2401723","DOI":"10.1002\/adhm.202401723","volume":"13","author":"Y Wang","year":"2024","unstructured":"Wang Y, Niu B, Tian Y, Lan H, Zhou Z, Li Y, et al. Mitoxantrone Combined with Engineered TRAIL-Nanovesicles for Enhanced Cancer Immunotherapy Via Converting Apoptosis into Pyroptosis. Adv Healthc Mater. 2024;13(28):e2401723.","journal-title":"Adv Healthc Mater"},{"issue":"9","key":"4607_CR95","doi-asserted-by":"publisher","first-page":"6845","DOI":"10.1021\/acsnano.3c04471","volume":"18","author":"JJ Baljon","year":"2024","unstructured":"Baljon JJ, Kwiatkowski AJ, Pagendarm HM, Stone PT, Kumar A, Bharti V, et al. A Cancer Nanovaccine for Co-Delivery of Peptide Neoantigens and Optimized Combinations of STING and TLR4 Agonists. ACS Nano. 2024;18(9):6845\u201362.","journal-title":"ACS Nano"},{"issue":"204","key":"4607_CR96","doi-asserted-by":"publisher","first-page":"204ra130","DOI":"10.1126\/scitranslmed.3006516","volume":"5","author":"AV Li","year":"2013","unstructured":"Li AV, Moon JJ, Abraham W, Suh H, Elkhader J, Seidman MA, et al. Generation of effector memory T cell-based mucosal and systemic immunity with pulmonary nanoparticle vaccination. Sci Transl Med. 2013;5(204):204ra130.","journal-title":"Sci Transl Med"},{"issue":"42","key":"4607_CR97","doi-asserted-by":"publisher","first-page":"e2419870","DOI":"10.1002\/adma.202419870","volume":"37","author":"Y Luo","year":"2025","unstructured":"Luo Y, Zhu C, Guo X, Xie Y, Sun Y, Lu D, et al. Engineering a Lipid Nanoparticle with Atypical Calcium Crystal Structure for Enhanced IFN\u03b2-Mediated Immunotherapy. Adv Mater. 2025;37(42):e2419870.","journal-title":"Adv Mater"},{"issue":"22","key":"4607_CR98","doi-asserted-by":"publisher","first-page":"5134","DOI":"10.1016\/j.biomaterials.2011.03.067","volume":"32","author":"B Kwong","year":"2011","unstructured":"Kwong B, Liu H, Irvine DJ. Induction of potent anti-tumor responses while eliminating systemic side effects via liposome-anchored combinatorial immunotherapy. Biomaterials. 2011;32(22):5134\u201347.","journal-title":"Biomaterials"},{"key":"4607_CR99","doi-asserted-by":"publisher","first-page":"121339","DOI":"10.1016\/j.biomaterials.2021.121339","volume":"281","author":"A Kheirolomoom","year":"2022","unstructured":"Kheirolomoom A, Kare AJ, Ingham ES, Paulmurugan R, Robinson ER, Baikoghli M, et al. In situ T-cell transfection by anti-CD3-conjugated lipid nanoparticles leads to T-cell activation, migration, and phenotypic shift. Biomaterials. 2022;281:121339.","journal-title":"Biomaterials"},{"issue":"4","key":"4607_CR100","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1021\/acs.molpharmaceut.9b01262","volume":"17","author":"M Maeta","year":"2020","unstructured":"Maeta M, Miura N, Tanaka H, Nakamura T, Kawanishi R, Nishikawa Y, et al. Vitamin E Scaffolds of pH-Responsive Lipid Nanoparticles as DNA Vaccines in Cancer and Protozoan Infection. Mol Pharm. 2020;17(4):1237\u201347.","journal-title":"Mol Pharm"},{"issue":"8","key":"4607_CR101","doi-asserted-by":"publisher","first-page":"5356","DOI":"10.1021\/acs.nanolett.9b01807","volume":"19","author":"H Huang","year":"2019","unstructured":"Huang H, Jiang CT, Shen S, Liu A, Gan YJ, Tong QS, et al. Nanoenabled Reversal of IDO1-Mediated Immunosuppression Synergizes with Immunogenic Chemotherapy for Improved Cancer Therapy. Nano Lett. 2019;19(8):5356\u201365.","journal-title":"Nano Lett"},{"key":"4607_CR102","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jconrel.2024.03.018","volume":"369","author":"Y Qin","year":"2024","unstructured":"Qin Y, Rouatbi N, Wang JT, Baker R, Spicer J, Walters AA, et al. Plasmid DNA ionisable lipid nanoparticles as non-inert carriers and potent immune activators for cancer immunotherapy. J Controlled Release. 2024;369:251\u201365.","journal-title":"J Controlled Release"},{"issue":"12","key":"4607_CR103","doi-asserted-by":"publisher","first-page":"3524","DOI":"10.4049\/jimmunol.1801634","volume":"202","author":"SK Gandhapudi","year":"2019","unstructured":"Gandhapudi SK, Ward M, Bush JPC, Bedu-Addo F, Conn G, Woodward JG. Antigen Priming with Enantiospecific Cationic Lipid Nanoparticles Induces Potent Antitumor CTL Responses through Novel Induction of a Type I IFN Response. J Immunol. 2019;202(12):3524\u201336.","journal-title":"J Immunol"},{"issue":"1","key":"4607_CR104","doi-asserted-by":"publisher","first-page":"10635","DOI":"10.1038\/s41467-024-54877-9","volume":"15","author":"AEI Hamouda","year":"2024","unstructured":"Hamouda AEI, Filtjens J, Brabants E, Kancheva D, Debraekeleer A, Brughmans J, et al. Intratumoral delivery of lipid nanoparticle-formulated mRNA encoding IL-21, IL-7, and 4-1BBL induces systemic anti-tumor immunity. Nat Commun. 2024;15(1):10635.","journal-title":"Nat Commun"},{"issue":"34","key":"4607_CR105","doi-asserted-by":"publisher","first-page":"23797","DOI":"10.1021\/acsnano.4c09094","volume":"18","author":"P Yuan","year":"2024","unstructured":"Yuan P, Yan X, Zong X, Li X, Yang C, Chen X, et al. Modulating Elasticity of Liposome for Enhanced Cancer Immunotherapy. ACS Nano. 2024;18(34):23797\u2013811.","journal-title":"ACS Nano"},{"issue":"5","key":"4607_CR106","doi-asserted-by":"publisher","first-page":"e2302691","DOI":"10.1002\/adhm.202302691","volume":"13","author":"Y Xu","year":"2024","unstructured":"Xu Y, Hu Y, Xia H, Zhang S, Lei H, Yan B, et al. Delivery of mRNA Vaccine with 1, 2-Diesters-Derived Lipids Elicits Fast Liver Clearance for Safe and Effective Cancer Immunotherapy. Adv Healthc Mater. 2024;13(5):e2302691.","journal-title":"Adv Healthc Mater"},{"issue":"24","key":"4607_CR107","doi-asserted-by":"publisher","first-page":"34965","DOI":"10.1021\/acsami.5c01194","volume":"17","author":"L Dong","year":"2025","unstructured":"Dong L, Liu D, Zhang J, Ling Y, Li X, Ou J, et al. Ultrasound-triggered NPC1L1-targeting nanobubbles for remodeling the tumor microenvironment in pancreatic cancer chemoimmunotherapy. ACS Appl Mater Interfaces. 2025;17(24):34965\u201381.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"6","key":"4607_CR108","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1158\/2326-6066.CIR-18-0650","volume":"7","author":"PY Lam","year":"2019","unstructured":"Lam PY, Kobayashi T, Soon M, Zeng B, Dolcetti R, Leggatt G, et al. NKT cell-driven enhancement of antitumor immunity induced by Clec9a-targeted tailorable nanoemulsion. Cancer Immunol Res. 2019;7(6):952\u201362.","journal-title":"Cancer Immunol Res"},{"issue":"48","key":"4607_CR109","doi-asserted-by":"publisher","first-page":"eadp7561","DOI":"10.1126\/sciadv.adp7561","volume":"10","author":"A Rong","year":"2024","unstructured":"Rong A, Han Z, Zhou M, Nie C, Zhu M, Cheng S, et al. Respiratory delivery of single low-dose nebulized PFCE-C25 NEs for lymphatic transport and durable stimulation of antitumor immunity in lung cancer. Sci Adv. 2024;10(48):eadp7561.","journal-title":"Sci Adv"},{"issue":"6","key":"4607_CR110","doi-asserted-by":"publisher","first-page":"9428","DOI":"10.1021\/acsnano.2c02314","volume":"16","author":"C Ji","year":"2022","unstructured":"Ji C, Zhao M, Wang C, Liu R, Zhu S, Dong X, et al. Biocompatible Tantalum Nanoparticles as Radiosensitizers for Enhancing Therapy Efficacy in Primary Tumor and Metastatic Sentinel Lymph Nodes. ACS Nano. 2022;16(6):9428\u201341.","journal-title":"ACS Nano"},{"issue":"27","key":"4607_CR111","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202503117","volume":"21","author":"C Deng","year":"2025","unstructured":"Deng C, Zhang J, Yang Y, Ding Y, An F, Wang F. Chemodynamic therapy enhanced (131)I-radiotherapy for efficient inhibition on cancer growth and metastasis. Small. 2025;21(27):e2503117.","journal-title":"Small"},{"issue":"9","key":"4607_CR112","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1021\/acs.bioconjchem.1c00393","volume":"32","author":"R Dai","year":"2021","unstructured":"Dai R, Peng X, Lin B, Xu D, Lv R. NIR II luminescence imaging for sentinel lymph node and enhanced chemo-\/photothermal therapy for breast cancer. Bioconjug Chem. 2021;32(9):2117\u201327.","journal-title":"Bioconjug Chem"},{"key":"4607_CR113","doi-asserted-by":"publisher","first-page":"4589","DOI":"10.2147\/IJN.S418766","volume":"18","author":"Y Yin","year":"2023","unstructured":"Yin Y, Sun J, Jiang T, Zhu L, Gu W, Wang S, et al. Combined Doxorubicin Mesoporous Carbon Nanospheres for Effective Tumor Lymphatic Metastasis by Multi-Modal Chemo-Photothermal Treatment in vivo. Int J Nanomed. 2023;18:4589\u2013600.","journal-title":"Int J Nanomed"},{"issue":"14","key":"4607_CR114","doi-asserted-by":"publisher","first-page":"13906","DOI":"10.1021\/acsnano.4c17491","volume":"19","author":"L Huang","year":"2025","unstructured":"Huang L, Li X, Zhang H, Liu F, Dai Z, Xiao F, et al. Zinc Ion-Coordinated Sericin Calcium Phosphate Nanovaccines Induce Hyperactive Dendritic Cells and Synergistic Activation of T Cells for Cancer Immunotherapy. ACS Nano. 2025;19(14):13906\u201326.","journal-title":"ACS Nano"},{"issue":"21","key":"4607_CR115","doi-asserted-by":"publisher","first-page":"19866","DOI":"10.1021\/acsnano.5c02541","volume":"19","author":"YH Lin","year":"2025","unstructured":"Lin YH, Chen CW, Chen MY, Xu L, Tian X, Cheung SH, et al. The Bacterial Outer Membrane Vesicle-Cloaked Immunostimulatory Nanoplatform Reinvigorates T Cell Function and Reprograms Tumor Immunity. ACS Nano. 2025;19(21):19866\u201389.","journal-title":"ACS Nano"},{"issue":"21","key":"4607_CR116","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.201900660","volume":"8","author":"Y Liu","year":"2019","unstructured":"Liu Y, Zhu X, Lu Y, Wang X, Zhang C, Sun H, et al. Antigen-inorganic hybrid flowers-based vaccines with enhanced room temperature stability and effective anticancer immunity. Advanced Healthcare Materials. 2019;8(21):e1900660.","journal-title":"Advanced Healthcare Materials"},{"issue":"24","key":"4607_CR117","doi-asserted-by":"publisher","first-page":"11649","DOI":"10.1039\/C9NR02920F","volume":"11","author":"DS Dumani","year":"2019","unstructured":"Dumani DS, Sun IC, Emelianov SY. Ultrasound-guided immunofunctional photoacoustic imaging for diagnosis of lymph node metastases. Nanoscale. 2019;11(24):11649\u201359.","journal-title":"Nanoscale"},{"key":"4607_CR118","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.actbio.2022.10.008","volume":"154","author":"L Li","year":"2022","unstructured":"Li L, Zhang M, Liu T, Li J, Sun S, Chen J, et al. Quercetin-ferrum nanoparticles enhance photothermal therapy by modulating the tumor immunosuppressive microenvironment. Acta Biomater. 2022;154:454\u201366.","journal-title":"Acta Biomater"},{"issue":"15","key":"4607_CR119","doi-asserted-by":"publisher","first-page":"18734","DOI":"10.1021\/acsami.3c03130","volume":"15","author":"Y Meng","year":"2023","unstructured":"Meng Y, Zhou J, Liu X, Zeng F, Wen T, Meng J, et al. CXC Chemokine Receptor Type 4 Antagonistic Gold Nanorods Induce Specific Immune Responses and Long-Term Immune Memory to Combat Triple-Negative Breast Cancer. ACS Appl Mater Interfaces. 2023;15(15):18734\u201346.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"43","key":"4607_CR120","doi-asserted-by":"publisher","first-page":"58337","DOI":"10.1021\/acsami.4c12748","volume":"16","author":"XW Mo","year":"2024","unstructured":"Mo XW, Phan NM, Nguyen TL, Kim J. H(2)O(2) self-supplying CaO(2) nanoplatform induces Ca(2+) overload combined with chemodynamic therapy to enhance cancer immunotherapy. ACS Appl Mater Interfaces. 2024;16(43):58337\u201345.","journal-title":"ACS Appl Mater Interfaces"},{"key":"4607_CR121","doi-asserted-by":"publisher","first-page":"1124152","DOI":"10.3389\/fimmu.2023.1124152","volume":"14","author":"T Huang","year":"2023","unstructured":"Huang T, Wu W, Wu J, Tan Y, Zhang M, Long H, et al. Perfluorocarbon nanodrug induced oxygen self-enriching sonodynamic therapy improves cancer immunotherapy after insufficient radiofrequency ablation. Front Immunol. 2023;14:1124152.","journal-title":"Front Immunol"},{"key":"4607_CR122","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.jconrel.2024.12.035","volume":"378","author":"X Ling","year":"2025","unstructured":"Ling X, Tian Z, Chen D, Zhang Y, Dong Z, He D, et al. Functionalized aluminum hydroxide-based self-adjuvanted nanovaccine orchestrates antitumor immune responses via Dectin-1 signaling. J Control Release. 2025;378:559\u201372.","journal-title":"J Control Release"},{"key":"4607_CR123","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2019.119417","volume":"220","author":"CG Da Silva","year":"2019","unstructured":"Da Silva CG, Camps MGM, Li T, Chan AB, Ossendorp F, Cruz LJ. Co-delivery of immunomodulators in biodegradable nanoparticles improves therapeutic efficacy of cancer vaccines. Biomaterials. 2019;220:119417.","journal-title":"Biomaterials"},{"issue":"2","key":"4607_CR124","doi-asserted-by":"publisher","first-page":"e2403143","DOI":"10.1002\/adhm.202403143","volume":"14","author":"XY Wang","year":"2025","unstructured":"Wang XY, Yan Y, Guo XR, Lu A, Jiang LX, Zhu YJ, et al. Enhanced Tumor Immunotherapy by Triple Amplification Effects of Nanomedicine on the STING Signaling Pathway in Dendritic Cells. Adv Healthc Mater. 2025;14(2):e2403143.","journal-title":"Adv Healthc Mater"},{"issue":"45","key":"4607_CR125","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201803397","volume":"30","author":"L Nuhn","year":"2018","unstructured":"Nuhn L, De Koker S, Van Lint S, Zhong Z, Catani JP, Combes F, et al. Nanoparticle-conjugate TLR7\/8 agonist localized immunotherapy provokes safe antitumoral responses. Adv Mater. 2018;30(45):e1803397.","journal-title":"Adv Mater"},{"issue":"20","key":"4607_CR126","doi-asserted-by":"publisher","first-page":"24134","DOI":"10.1021\/acsami.3c02646","volume":"15","author":"R Zhang","year":"2023","unstructured":"Zhang R, Qin X, Lu J, Xu H, Zhao S, Li X, et al. Chemodynamic\/photothermal synergistic cancer immunotherapy based on yeast microcapsule-derived Au\/Pt nanoparticles. ACS Appl Mater Interfaces. 2023;15(20):24134\u201348.","journal-title":"ACS Appl Mater Interfaces"},{"key":"4607_CR127","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6528\/ace97b","author":"J Weng","year":"2023","unstructured":"Weng J, Yang J, Wang W, Wen J, Fang M, Zheng G, et al. Application of microneedles combined with dendritic cell-targeted nanovaccine delivery system in percutaneous immunotherapy for triple-negative breast cancer. Nanotechnology. 2023. https:\/\/doi.org\/10.1088\/1361-6528\/ace97b.","journal-title":"Nanotechnology"},{"issue":"18","key":"4607_CR128","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202310673","volume":"36","author":"Q Sun","year":"2024","unstructured":"Sun Q, Li Y, Shen W, Shang W, Xu Y, Yang J, et al. Breaking-down tumoral physical barrier by remotely unwrapping metal-polyphenol-packaged hyaluronidase for optimizing photothermal\/photodynamic therapy-induced immune response. Adv Mater. 2024;36(18):e2310673.","journal-title":"Adv Mater"},{"issue":"7","key":"4607_CR129","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1016\/j.biomaterials.2012.11.038","volume":"34","author":"R Liu","year":"2013","unstructured":"Liu R, Gilmore DM, Zubris KA, Xu X, Catalano PJ, Padera RF, et al. Prevention of nodal metastases in breast cancer following the lymphatic migration of paclitaxel-loaded expansile nanoparticles. Biomaterials. 2013;34(7):1810\u20139.","journal-title":"Biomaterials"},{"issue":"5","key":"4607_CR130","doi-asserted-by":"publisher","first-page":"8472","DOI":"10.1021\/acsnano.2c03379","volume":"16","author":"J Hwang","year":"2022","unstructured":"Hwang J, An EK, Kim SJ, Zhang W, Jin JO. Escherichia coli Mimetic Gold Nanorod-Mediated Photo- and Immunotherapy for Treating Cancer and Its Metastasis. ACS Nano. 2022;16(5):8472\u201383.","journal-title":"ACS Nano"},{"key":"4607_CR131","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.actbio.2024.12.039","volume":"193","author":"MA Farooq","year":"2025","unstructured":"Farooq MA, Johnston APR, Trevaskis NL. Impact of nanoparticle properties on immune cell interactions in the lymph node. Acta Biomater. 2025;193:65\u201382.","journal-title":"Acta Biomater"},{"key":"4607_CR132","doi-asserted-by":"publisher","first-page":"101068","DOI":"10.1016\/j.mtbio.2024.101068","volume":"26","author":"J Wang","year":"2024","unstructured":"Wang J, Zhang Z, Liang R, Chen W, Li Q, Xu J, et al. Targeting lymph nodes for enhanced cancer vaccination: From nanotechnology to tissue engineering. Mater Today Bio. 2024;26:101068.","journal-title":"Mater Today Bio"},{"key":"4607_CR133","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3389\/fimmu.2019.00347","volume":"10","author":"DAP Louie","year":"2019","unstructured":"Louie DAP, Liao S. Lymph Node Subcapsular Sinus Macrophages as the Frontline of Lymphatic Immune Defense. Front Immunol. 2019;10:347.","journal-title":"Front Immunol"},{"issue":"8","key":"4607_CR134","doi-asserted-by":"publisher","first-page":"9478","DOI":"10.1021\/acsnano.0c02240","volume":"14","author":"YN Zhang","year":"2020","unstructured":"Zhang YN, Poon W, Sefton E, Chan WCW. Suppressing subcapsular sinus macrophages enhances transport of nanovaccines to lymph node follicles for robust humoral immunity. ACS Nano. 2020;14(8):9478\u201390.","journal-title":"ACS Nano"},{"issue":"3","key":"4607_CR135","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.ymthe.2024.01.020","volume":"32","author":"K Kubara","year":"2024","unstructured":"Kubara K, Yamazaki K, Miyazaki T, Kondo K, Kurotaki D, Tamura T, et al. Lymph node macrophages drive innate immune responses to enhance the anti-tumor efficacy of mRNA vaccines. Mol Ther. 2024;32(3):704\u201321.","journal-title":"Mol Ther"},{"key":"4607_CR136","doi-asserted-by":"publisher","DOI":"10.3390\/nano11071700","author":"IC Sun","year":"2021","unstructured":"Sun IC, Jo S, Dumani D, Yun WS, Yoon HY, Lim DK, et al. Theragnostic Glycol Chitosan-conjugated gold nanoparticles for photoacoustic imaging of regional lymph nodes and delivering tumor antigen to lymph nodes. Nanomaterials. 2021. https:\/\/doi.org\/10.3390\/nano11071700.","journal-title":"Nanomaterials"},{"issue":"1\u20132","key":"4607_CR137","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.ijpharm.2017.11.031","volume":"535","author":"J Widmer","year":"2018","unstructured":"Widmer J, Thauvin C, Mottas I, Nguyen VN, Delie F, All\u00e9mann E, et al. Polymer-based nanoparticles loaded with a TLR7 ligand to target the lymph node for immunostimulation. Int J Pharm. 2018;535(1\u20132):444\u201351.","journal-title":"Int J Pharm"},{"issue":"13","key":"4607_CR138","doi-asserted-by":"publisher","first-page":"6329","DOI":"10.7150\/thno.110305","volume":"15","author":"W Wei","year":"2025","unstructured":"Wei W, Yang X, Chen Y, Che M, Ye Y, Deng Y, et al. Boosting mRNA cancer vaccine efficacy via targeting Irg1 on macrophages in lymph nodes. Theranostics. 2025;15(13):6329\u201346.","journal-title":"Theranostics"},{"key":"4607_CR139","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.603039","volume":"11","author":"NM La-Beck","year":"2020","unstructured":"La-Beck NM, Islam MR, Markiewski MM. Nanoparticle-induced complement activation: implications for cancer nanomedicine. Front Immunol. 2020;11:603039.","journal-title":"Front Immunol"},{"issue":"10","key":"4607_CR140","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1038\/nbt1332","volume":"25","author":"ST Reddy","year":"2007","unstructured":"Reddy ST, van der Vlies AJ, Simeoni E, Angeli V, Randolph GJ, O\u2019Neil CP, et al. Exploiting lymphatic transport and complement activation in nanoparticle vaccines. Nat Biotechnol. 2007;25(10):1159\u201364.","journal-title":"Nat Biotechnol"},{"issue":"5","key":"4607_CR141","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1021\/mp500589c","volume":"12","author":"SN Mueller","year":"2015","unstructured":"Mueller SN, Tian S, DeSimone JM. Rapid and persistent delivery of antigen by lymph node targeting PRINT nanoparticle vaccine carrier to promote humoral immunity. Mol Pharm. 2015;12(5):1356\u201365.","journal-title":"Mol Pharm"},{"issue":"6427","key":"4607_CR142","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1126\/science.aat9120","volume":"363","author":"T Tokatlian","year":"2019","unstructured":"Tokatlian T, Read BJ, Jones CA, Kulp DW, Menis S, Chang JYH, et al. Innate immune recognition of glycans targets HIV nanoparticle immunogens to germinal centers. Science. 2019;363(6427):649\u201354.","journal-title":"Science"},{"issue":"2","key":"4607_CR143","doi-asserted-by":"publisher","first-page":"110217","DOI":"10.1016\/j.celrep.2021.110217","volume":"38","author":"BJ Read","year":"2022","unstructured":"Read BJ, Won L, Kraft JC, Sappington I, Aung A, Wu S, et al. Mannose-binding lectin and complement mediate follicular localization and enhanced immunogenicity of diverse protein nanoparticle immunogens. Cell Rep. 2022;38(2):110217.","journal-title":"Cell Rep"},{"issue":"4","key":"4607_CR144","doi-asserted-by":"publisher","first-page":"633","DOI":"10.2174\/0122117385300471240408063205","volume":"13","author":"S Singh","year":"2025","unstructured":"Singh S, Chauhan V, Barik P. Nano-based theranostics approach in the management of cancer: review. Pharm Nanotechnol. 2025;13(4):633\u201347.","journal-title":"Pharm Nanotechnol"},{"issue":"10\u201311","key":"4607_CR145","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.addr.2011.05.016","volume":"63","author":"LM Kaminskas","year":"2011","unstructured":"Kaminskas LM, Porter CJ. Targeting the lymphatics using dendritic polymers (dendrimers). Adv Drug Deliv Rev. 2011;63(10\u201311):890\u2013900.","journal-title":"Adv Drug Deliv Rev"},{"key":"4607_CR146","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.113914","volume":"179","author":"Y Ding","year":"2021","unstructured":"Ding Y, Li Z, Jaklenec A, Hu Q. Vaccine delivery systems toward lymph nodes. Adv Drug Deliv Rev. 2021;179:113914.","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"4607_CR147","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1002\/cpt.2186","volume":"109","author":"EMB Scholz","year":"2021","unstructured":"Scholz EMB, Kashuba ADM. The lymph node reservoir: physiology, HIV infection, and antiretroviral therapy. Clin Pharmacol Ther. 2021;109(4):918\u201327.","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"4607_CR148","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1002\/eji.200737984","volume":"38","author":"V Manolova","year":"2008","unstructured":"Manolova V, Flace A, Bauer M, Schwarz K, Saudan P, Bachmann MF. Nanoparticles target distinct dendritic cell populations according to their size. Eur J Immunol. 2008;38(5):1404\u201313.","journal-title":"Eur J Immunol"},{"issue":"4","key":"4607_CR149","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s12274-019-2301-3","volume":"12","author":"GP Howard","year":"2019","unstructured":"Howard GP, Verma G, Ke X, Thayer WM, Hamerly T, Baxter VK, et al. Critical Size Limit of Biodegradable Nanoparticles for Enhanced Lymph Node Trafficking and Paracortex Penetration. Nano Res. 2019;12(4):837\u201344.","journal-title":"Nano Res"},{"issue":"3","key":"4607_CR150","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1021\/acs.molpharmaceut.9b01182","volume":"17","author":"T Nakamura","year":"2020","unstructured":"Nakamura T, Kawai M, Sato Y, Maeki M, Tokeshi M, Harashima H. The effect of size and charge of lipid nanoparticles prepared by microfluidic mixing on their lymph node transitivity and distribution. Mol Pharm. 2020;17(3):944\u201353.","journal-title":"Mol Pharm"},{"issue":"10","key":"4607_CR151","doi-asserted-by":"publisher","first-page":"7226","DOI":"10.1021\/acs.nanolett.9b02834","volume":"19","author":"YN Zhang","year":"2019","unstructured":"Zhang YN, Lazarovits J, Poon W, Ouyang B, Nguyen LNM, Kingston BR, et al. Nanoparticle size influences antigen retention and presentation in lymph node follicles for humoral immunity. Nano Lett. 2019;19(10):7226\u201335.","journal-title":"Nano Lett"},{"issue":"3","key":"4607_CR152","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.tips.2026.01.003","volume":"47","author":"W Ye","year":"2026","unstructured":"Ye W, Li X, Chandra J, Yu J, Zhou T, Li Z. Targeting metabolic vulnerabilities with advanced delivery systems. Trends Pharmacol Sci. 2026;47(3):309\u201324.","journal-title":"Trends Pharmacol Sci"},{"issue":"13","key":"4607_CR153","doi-asserted-by":"publisher","first-page":"5914","DOI":"10.1073\/pnas.1812800116","volume":"116","author":"A Mayer","year":"2019","unstructured":"Mayer A, Zhang Y, Perelson AS, Wingreen NS. Regulation of T cell expansion by antigen presentation dynamics. Proc Natl Acad Sci U S A. 2019;116(13):5914\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"4607_CR154","doi-asserted-by":"publisher","first-page":"795","DOI":"10.4049\/jimmunol.171.2.795","volume":"171","author":"T Storni","year":"2003","unstructured":"Storni T, Ruedl C, Renner WA, Bachmann MF. Innate immunity together with duration of antigen persistence regulate effector T cell induction. J Immunol. 2003;171(2):795\u2013801.","journal-title":"J Immunol"},{"key":"4607_CR155","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.copbio.2021.12.012","volume":"74","author":"Y Yang","year":"2022","unstructured":"Yang Y, Santamaria P. Antigen-specific nanomedicines for the treatment of autoimmune disease: target cell types, mechanisms and outcomes. Curr Opin Biotechnol. 2022;74:285\u201392.","journal-title":"Curr Opin Biotechnol"},{"issue":"1","key":"4607_CR156","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12943-024-02214-5","volume":"24","author":"M Wang","year":"2025","unstructured":"Wang M, Yu F, Zhang Y. Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges. Mol Cancer. 2025;24(1):26.","journal-title":"Mol Cancer"},{"issue":"6","key":"4607_CR157","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1172\/JCI79915","volume":"125","author":"MC Hanson","year":"2015","unstructured":"Hanson MC, Crespo MP, Abraham W, Moynihan KD, Szeto GL, Chen SH, et al. Nanoparticulate STING agonists are potent lymph node-targeted vaccine adjuvants. J Clin Invest. 2015;125(6):2532\u201346.","journal-title":"J Clin Invest"},{"key":"4607_CR158","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.jconrel.2020.11.017","volume":"330","author":"M Wehbe","year":"2021","unstructured":"Wehbe M, Wang-Bishop L, Becker KW, Shae D, Baljon JJ, He X, et al. Nanoparticle delivery improves the pharmacokinetic properties of cyclic dinucleotide STING agonists to open a therapeutic window for intravenous administration. J Control Release. 2021;330:1118\u201329.","journal-title":"J Control Release"},{"issue":"7493","key":"4607_CR159","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nature12978","volume":"507","author":"H Liu","year":"2014","unstructured":"Liu H, Moynihan KD, Zheng Y, Szeto GL, Li AV, Huang B, et al. Structure-based programming of lymph-node targeting in molecular vaccines. Nature. 2014;507(7493):519\u201322.","journal-title":"Nature"},{"issue":"28","key":"4607_CR160","doi-asserted-by":"publisher","first-page":"e2103677","DOI":"10.1002\/advs.202103677","volume":"9","author":"S Correa","year":"2022","unstructured":"Correa S, Meany EL, Gale EC, Klich JH, Saouaf OM, Mayer AT, et al. Injectable Nanoparticle-Based Hydrogels Enable the Safe and Effective Deployment of Immunostimulatory CD40 Agonist Antibodies. Adv Sci (Weinh). 2022;9(28):e2103677.","journal-title":"Adv Sci (Weinh)"},{"issue":"3","key":"4607_CR161","doi-asserted-by":"publisher","first-page":"102588","DOI":"10.1016\/j.omtn.2025.102588","volume":"36","author":"O Engstrand","year":"2025","unstructured":"Engstrand O, Joas G, Miranda MC, Yan X, Lenart K, Cerveira RA, et al. Immunogenicity and innate immunity to high-dose and repeated vaccination of modified mRNA versus unmodified mRNA. Mol Ther Nucleic Acids. 2025;36(3):102588.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"13","key":"4607_CR162","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.3390\/nano14131149","volume":"14","author":"M Baselga","year":"2024","unstructured":"Baselga M, G\u00fcemes A, Yus C, Alejo T, Sebasti\u00e1n V, Arribas D, et al. Melanin-based nanoparticles for lymph node tattooing: experimental, histopathological and ultrastructural study. Nanomaterials (Basel). 2024;14(13):1149.","journal-title":"Nanomaterials (Basel)"},{"issue":"1","key":"4607_CR163","doi-asserted-by":"publisher","first-page":"29512","DOI":"10.1038\/s41598-024-80931-z","volume":"14","author":"M Baselga","year":"2024","unstructured":"Baselga M, G\u00fcemes A, Arruebo M, Yus C, Alejo T, Sebasti\u00e1n V, et al. Preclinical evaluation of polymer encapsulated carbon-based nano and microparticles for sentinel lymph node tattooing. Sci Rep. 2024;14(1):29512.","journal-title":"Sci Rep"},{"issue":"5","key":"4607_CR164","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1021\/nn901421v","volume":"4","author":"T Pons","year":"2010","unstructured":"Pons T, Pic E, Lequeux N, Cassette E, Bezdetnaya L, Guillemin F, et al. Cadmium-free CuInS2\/ZnS quantum dots for sentinel lymph node imaging with reduced toxicity. ACS Nano. 2010;4(5):2531\u20138.","journal-title":"ACS Nano"},{"issue":"7","key":"4607_CR165","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1021\/nl901534q","volume":"9","author":"JA Fitzpatrick","year":"2009","unstructured":"Fitzpatrick JA, Andreko SK, Ernst LA, Waggoner AS, Ballou B, Bruchez MP. Long-term persistence and spectral blue shifting of quantum dots in vivo. Nano Lett. 2009;9(7):2736\u201341.","journal-title":"Nano Lett"},{"issue":"1","key":"4607_CR166","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15563650.2020.1814316","volume":"59","author":"MR Fettiplace","year":"2021","unstructured":"Fettiplace MR, Pichurko AB. Heterogeneity and bias in animal models of lipid emulsion therapy: a systematic review and meta-analysis. Clin Toxicol (Phila). 2021;59(1):1\u201311.","journal-title":"Clin Toxicol (Phila)"},{"issue":"3","key":"4607_CR167","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.jamcollsurg.2011.11.006","volume":"214","author":"OV Khullar","year":"2012","unstructured":"Khullar OV, Griset AP, Gibbs-Strauss SL, Chirieac LR, Zubris KA, Frangioni JV, et al. Nanoparticle migration and delivery of Paclitaxel to regional lymph nodes in a large animal model. J Am Coll Surg. 2012;214(3):328\u201337.","journal-title":"J Am Coll Surg"},{"issue":"12","key":"4607_CR168","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1002\/ijc.34453","volume":"152","author":"M Ishihara","year":"2023","unstructured":"Ishihara M, Nishida Y, Kitano S, Kawai A, Muraoka D, Momose F, et al. A phase 1 trial of NY-ESO-1-specific TCR-engineered T-cell therapy combined with a lymph node-targeting nanoparticulate peptide vaccine for the treatment of advanced soft tissue sarcoma. Int J Cancer. 2023;152(12):2554\u201366.","journal-title":"Int J Cancer"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04607-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04607-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04607-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T04:00:15Z","timestamp":1785816015000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04607-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,31]]},"references-count":168,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4607"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04607-8","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,31]]},"assertion":[{"value":"13 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"715"}}